statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for LUNG
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsEqual-Weight Jan 2022Morgan StanleyMaintainsEqual-Weight
 View More Analyst...

Navigating 6 Analyst Ratings For Pulmonx

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ( Pulmonx or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Co. (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 17.5% from...

Short Interest in Pulmonx Co. (NASDAQ:LUNG) Decreases By 17.5%

Shares of Pulmonx Co. (NASDAQ:LUNG  Get Free Report) have been assigned a consensus recommendation of Moderate Buy from the six ratings firms that are currently covering the...

Pulmonx Co. (NASDAQ:LUNG) Given Consensus Rating of "Moderate Buy" by Analysts

This is a signal that LUNG's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Pulmonx (LUNG, $9.32) RSI Indicator left the oversold zone on March 19, 2024

This indicator may be signaling LUNG's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Pulmonx (LUNG, $9.32) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024

This is a Bullish indicator signaling LUNG's price could rise from here. Traders may explore going long the stock or buying call options...

Pulmonx (LUNG, $8.83) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 18, 2024

REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ( Pulmonx or the Company ), a global leader in minimally invasive treatments for lung disease, today...

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Pulmonx Corporation (Nasdaq: LUNG) (Pulmonx or the Company), a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), today announced the treatment of the...

Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial

Pulmonx (NASDAQ:LUNG  Get Free Report) had its price objective upped by equities researchers at Citigroup from $16.00 to $17.00 in a research report issued on Friday, Benzinga reports. The...

Pulmonx (NASDAQ:LUNG) Given New $17.00 Price Target at Citigroup

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Watchers	251
52-Wk Low	$7.11
52-Wk High	$14.84

Volume	158,994.00
52-Wk High	$14.84
52-Wk Low	$7.11

LUNG Pulmonx Corp

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community